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The Photometric Autotitration of free Fatty Acids1)
By J. KEUL, N. LiNNET2) and E. ESCHENBRUCH
From the Department of Internal Medicine of the University of Freiburg\Br., Germany
(Eingegangen am 22. März 1968)
A description is given of a new method for determining free fatty acids in blood plasma. The free fatty acids are extracted from the plasma,
transferred to heptane and washed with H2SO4 (O.OlN). The earlier two-phase tritration procedure is now performed in a one-phase
medium by means of an autoburette using tetrabutylammoniumhydrcxide. A curve, simultaneously recorded by means of a com-
pensation recorder, allows for an accurate determination of the transition point of the titration, and accurate and reproducible
measuring values can therefore be obtained. An unambiguous determination of small arterio-venous differences is likewise possible by
this method.
Es wird eine neue Methode zur Bestimmung von freien Fettsäuren im Blutplasma beschrieben. Die freien Fettsäuren werden aus dem
Plasma extrahiert, in Heptan überführt und mit H2SO4 ( , ) gewaschen. Statt der bisherigen Titration im Zwei-Phasen-Medium wird
in einem einphasischen Medium mit einer Autobürette unter Verwendung von Tetrabutylammoniumhydroxid titriert; eine gleichzeitig
von einem Kompensationsschreiber aufgezeichnete Kurve läßt eine genaue Bestimmung des Titrationsumschlagpunktes zu, und somit
können exakte, reproduzierbare Meßwerte erzielt werden. Kleine arteriovenöse Differenzen lassen sich mit dieser Methode noch ein-
deutig bestimmen.
Ever since DOLE (1) and GORDON and CHERKES (2)
indicated new methods for the quantitative determina-
tion of free fatty acids in blood plasma, various teams
of scientists have devoted their studies to the detection
of free fatty acids in fluids and tissue, and in the course
of their experiments repeatedly modified the methods
to suit their particular requirements. The many modifi-
cations of the original procedure for determining free
fatty acids show only too clearly that no method so far
developed satisfies the requirements.
A critical comparison of several fairly closely related
methods, as undertaken by NELSON (3), indicated that
the procedure advocated by DOLE — viz., an extraction
process for transferring the free fatty acids of the plasma
to an organic fluid — was of fundamental importance in
making quantitative analyses. Apparently (3), not only
acids like lactic acid and acetic, but also phosphatides, gave
free fatty acid values that were too high when determined
according to DOLE (1). More accurate results can be
obtained through washing with H2SO4. This is due to
a better separation of isopropanol/water and heptane (3).
Since the heptane phase will no longer contain water/
isopropanol with water-soluble, base-binding substances,
the free fatty acids will be included only in the non-
aqueous medium.
Such titrations carried out in a non-aqueous environ-
ment with aqueous NaOH were not satisfactory, as the
production of two phases influenced both the accuracy
and the reproducibility.
In 1965 KELLEY (4) first indicated a titration procedure
for determining free fatty 'acids, in which TBAH3),
which is soluble in heptane and isopropanol, was used
as titrant. As indicator, he used phenol red dissolved in
ethanol.
The present work concerns a determination of free fatty
acids based on the experience so far gathered (1, 3—7).
*) Supported by a grant from the Deutsche Forschungsgemein-
schaft (German Research Association) and the Kuratorium für
Sportmedizin (Cologne).
2) Radiometer A/S, Copenhagen/Denmark.
3) Abbreviation: TBAH = tetrabutylammoniumhydroxide.
The free fatty acids are transferred to a heptane phase
and titrated with TBAH, using l-(2-hydroxy-benzene)
azo-2^naphthol as the indicator. The titration is perform-
ed automatically by means of the Radiometer Titrigraph
and is continuously recorded.
Method
Blood Sampling
A minimum of 3 m/ whole blood is drawn into a heparinized
syringe4). Once filled, the syringe is sealed and vigorously shaken
several times to ensure complete heparinization, and it is then set
aside in a 10 m/ centrifuge tube containing ice water. Afterwards,
the blood is centrifuged for 10 to 15 min. at 2000 r. p. m., and the
plasma is then removed.
Following this, the free fatty acid content must either be deter-
mined immediately, or the plasma must be stored at —30° C.
Preparing the Blood Plasma
The task of preparing a sample for titration can be divided into
an ex trad ion procedure (1, 5) and a washing procedure.
Laboratory equipment
25 m/ test tubes with tapered glass stoppers
10 m/ centrifuge tubes
Beakers (50—150 m/)
Graduated cylinders (100, 500 m/)
100 m/ volumetric flasks with tightly-£tting tapered glass stoppers
for standard solutions
500 m/ volumetric flasks with tightly-fitting tapered glass stoppers
for extraction mixture
100 /, 1000 /, 2000 micro-pipettes; also 1m/, 2m/, 3m/,
4 m/, 5 m/, 10 m/ and 15m/ pipettes.
'Reagents
a) .Extraction mixture:
40 parts isopropanol
10 parts heptane
^ 1 part H2SO4, IN.
° The extraction mixture must be protected from atmospheric
carbon-dioxide and from evaporation (which occurs at different
4) In agreement with the report1 of FREDERICKSON and GORDON
(8), we did not find any lipolysis in vitro under the influence of
heparin. Duplicate analyses, in which blood plasma was obtained
after admixture of heparin or sodium citrate, differed by less
than ± 2%.
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speed for the different components) by keeping it in a tightly-
stoppered bottle.
b) Washing solution:
H2SO4, O.OlN
1 ml H2SO4, I.ON is poured into a 100m/ volumetric flask and
diluted with twicedistilled water to make 100 m/ solution.
c) Standard solutions:
Palmitic acid stock solution: (24IHM):
0.6154 g palmitic acid dissolved in 1000 m/ heptane.
Palmi t ic acid "Standard A" (1.2 ΠΙΜ):
5 ml "stock solution" are diluted with heptane to make 100 ml.
Palmi t ic acid "Standard B" (0.3 HIM):
25 ml "Standard A" are diluted with heptane to make 100 ml.
d) Titrant:
0,004M tetrabutylammoniumhydroxide in isopropanol/methanol.
e) Indicator:
0.1% phenol red in cthanol.
Great care must be exercised in handling the palmitic acid stad-
ards. The storage flasks must always be tightly stoppered. After
a sample is drawn, the stopper must immediately be reinserted
into the flask.
Extraction procedure
5 m/ extraction solution +1 ml plasma are pipetted into a 25 ml
test tube with tapered glass stopper and then shaken vigorously
so that the albumin is precipitated and drops to the bottom of the
test tube.
The sample is left standing for 10 min., and 3 ml heptane and
3 m/ twice-distilled water are then added, following which the
sample is shaken vigorously for l min. and again set aside for
5 min.
The extraction mixture will now separate into two phases: at the
top into a (at first) small phase of heptane, which, however,
rapidly grows to more than 4 m/; at the bottom into a water/
isopropanol phase containing flocculated albumin. The interface
between the phases becomes sharply defined after a few minutes,
so that the heptane phase at the top is easily removed.
Washing procedure
3 ml O.OlN H2SO4 and 3 ml of the heptane phase from the ex-
traction procedure are pipetted into a 10 ml centrifuge tube
furnished with a tapered stopper. The mixture is then shaken
vigorously for l min. and left standing for another 10 min. The
mixture is now placed in a centrifuge and centrifuged for 10 min.
at 2000 r. p. m.
Afterwards the mixture will again be separated into two phases of
which the upper one consists of heptane (> 2 m/) with the free
fatty acids.
Titrating, Recording and Computing
For use in titration, 2 ml of the washed heptane phase are trans-
ferred to a titration beaker together with 15 ml isopropanol and
ΙΟΟμ/indicator5). The indicator makes the mixture red. The titration
is carried out \vith TBAH6) as titrant in a one-phase medium and
by means of the titration equipment (SBR2c, TTTlc, ABUlb,
TTA4, PH 8604) from Radiometer, Copenhagen (see Fig. 1).
Detailed instructions for operating the titration equipment can be
found in the Radiometer manuals for the instruments.
The titration beaker is placed in the titration head (photo-cell
chamber) of TTA4 (Fig. 2), and the sample is bubbled 1 to 2 min.
with KOH-washed N2 under constant stirring. The gas inlet
tube is then raised above the surface of the sample so that an
atmosphere of nitrogen is created within the beaker7).
When all the controls of the equipment have been accurately
adjusted, the titration proper will take from 2 to 6 min. to complete
(depending on the amount of free fatty acids in the sample). The
stirrer is constantly operated while titrant is added to ensure a
uniform distribution, but this does not have any noticeable effect
on the efficiency of the photo-cell.
When the titration is completed, the titration beaker is rinsed
twice with isopropanol, and it is then ready for the next measure-
ment.
5) l-(2-hydroxyben2ene)-azo-2-naphthol (available from Radio-
meter, Copenhagen, as Indicator, type S 5203).
6) Tetrabutylammoniumhydroxide, E. Merck, AG, Darmstadt.
7) Tests where bubbling with N2 was omitted did not give repro-
ducible results.
Fig. 1
The Radiometer equipment: Titrigraph, Titrator, Autoburette, Photo-cell chamber and Supply Unit
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Fig. 2
The installation of the beaker in the photo-cell chamber
The course of the titration is recorded via a photo-cell. The
intensity of light (from a built-in light source) traverses a stand-
ardized titration beaker containing the isopropanol-heptane-
indicator test solution with its contents of dissolved free fatty
acids, and is detected by a photo-cell connected to the Titrator
TTTlc (Fig. 1). Immediately before the titration is performed, the
light intensity, as measured by the photo-cell, is balanced against
the zero setting of the titrator by means of the balance control of
the Supply Unit (PHA804 — Fig. 1).
Once the set-up has been adjusted and the titration process is set
going from the Titrator, the Auto-Burette (ABUlb — Fig. 1)
commences delivery of titrant. When a change occurs in light
intensity because of titrant addition, and the system therefore is
caused to depart from the preset value, the Auto-Burette stops,
and the combined compensation voltage and chart feed of the
Recorder, SBR2c (see Fig. 1) is set in motion until the measuring
value again corresponds to the original setting. When this com-
pensation is completed, the Titrator stops the chart feed motor
and starts the Auto-Burette again.
The titration process is an alternation between titrant delivery and
compensation of the resultant change in light intensity. The
control link between both functions is the Titrator in conjunction
with the photo-cell.
When titrant is added, the pen of the Titrigraph is simultaneously
started. During this phase of the alternating process, all horizontal
portions of the curve are recorded (see Fig. 3). During the com-
pensation phase, the pen is stationary, such that the forward
movement of the chart causes the vertical portions of the curve to
be traced. The titration curve thus produced is a stepped line
consisting of horizontal and. vertical portions (as seen, 'greatly
exaggerated, in Fig. 3).
A line joining all points on this curve at which the recorder has
only just compensated for the titrant increment and a new titrant
increment is about to be delivered, is the true titration curve. The
slope of the curve is dependent on the relationship between
titrant increments and compensation of the resulting deviation.
If only a slight colour change is produced, even though a large
increment of titrant has been added, the run of the curve will be
practically horizontal. If the colour change is great, e. g. in the
range bracketing the transition point of the indicator, then the
corresponding compensation is equally great, and the curve pro-
duced will be steep.
The selected indicator does not change from red to blue before
the free fatty acids have been titrated. The titration of fatty acids
is completed at the point where the oblique part of the curve
begins.
The volume of titrant needed to titrate the fatty acids can be
found at the intersection of the extrapolated horizontal and
oblique portions of the curve (see Fig. 4).
In order to determine the free fatty acid content in a sample, it is
necessary to make standard measurements under identical con-
ditions. 1.2 rriM and 0.3 mM Solutions of palmitic acid are used as
standards. These standards are prepared in exactly the same way
as the plasma sample; thus, for the extraction process, 5 m/ ex-
Compensaiion
T/front addition
True curve
80 75 " " " 3 0 "
% of total tttrant capacity of the autoburetie
Fig. 3
The true titration curve and the titration curve like a stepped line as
a function of titrant delivery and light intensity (explanation see text)
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Fig. 4
Curve of standard titration. Determination of the transitionpoint by
drawning
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traction solution and 1 ml standard A, or standard B, are added
with a pipette. Since this 1 m/ standard is a heptane solution
(1 ml plasma is an aqueous solution), 2 ml heptane and 4 ml
distilled water are then added instead of 3 ml heptane and 3 ml
distilled water. This ensures that equal portions of isopropanol,
heptane and water are contained in the standard sample as well as
in the plasma.
A calculation of the content of free fetty acids in a sample in
accordance with end-point and standard titrations is made by
means of the following equation:
[c(m—n) + a · n — b · m]10e
μ equiv. free fetty acids/m/Λ. ,
a — b
where
a = titrant consumption (in ml) in 'Standard A* titration
b = titrant consumption (in m/) in 'Standard B' titration
c = titrant consumption (in ml) in 'Sample* titration
m = molarity of 'Standard A*
η = molarity of 'Standard B'
Results and Discussion
Determination of palmitic acid solutions of specific concentra-
tions
Solutions having different contents of palmitic acid were
each washed once with 0.005N H2SO4 or once with
O.OlN H2SO4 in three duplicate tests, and then determin-
ed (Fig. 5).
7-
1 2 3 * S f 7
Palmitic acid used [μΥαΙ/ml}
Fig. 5
Measured concentrations of palmitic acid in solutions, containing
0.0—7.25 μ equiv./ml
• Washing with 0.01 N HZSQ4
ο Washing with 0.005N HtSO4
Below 0.30 μ equiv. palmitic acid per m/, as much as 3% more palmitic
acid than actually used were detected. In the range from 0.30 μ equiv.
palmitic acid per mZ to 2.40 μ equiv. palmitic acid per ml. using
0.01 N H2SO4, the deviation in measured quantity of the specified
amount of palmitic acid was ± 1 %
In the range from 2.40 μ equiv. palmitic acid per ml to 4.80 μ equiv.
palmitic acid per ml 3% less than the specified amount were detected,
and above 4.80 μ equiv. palmitic acid per m/, the deviation between
quantity used and quantity measured approached —5 %
The error when using 0.005N H2SO4 was almost twice
as great. Greatest accuracy was obtained with O.OlN
H2SO4 with concentrations of fatty acids lying between
0.30 μ equiv. per m/ and 2.40 μ equiv. per m/.
Recovery
a) To an albumin solution with a low free fatty acid
content '(4 g albun n/lOO m/ twice-distilled water) was
added a measured quantity (0.1 mMol) of palmitic acid.
The palmitic acid was afterwards recovered with an
error less than 4% (tab. 1, 2).
Reproducibility
In a series of analyses performed under identical condi-
tions, the difference between the individual values ob-
tained was less than ± 1% (tab. 3).
Tab. 1
Recovery of palmitic acid in an albumin solution (n = 3)
Albumin solution Palmitic acid Measured Difference
content of free added quantity (/* equiv./m/)
fatty acids (μ equiv./m/) (μ equiv./m/)(μ equiv./m/)
0.120 1.000 1.080 —0.40
Tab. 2
Recovery of palmitic acid, dissolved in heptane added to plasma
Plasma content
of free fatty
acids(μ equiv./m/)
0.676
0.530
0.690
0.676
0.530
0.690
0.390
Palmitic acid
added(μ equiv./m/)
0.300
0.300
0.300
0.600
0.600
0.600
0.600
Measured
quantity(μ equiv./m/)
0.969
0.844
0.960
1.283
1.146 ·
1.250
0.988
Difference(μ equiv./m/)
—0.007
+ 0.014
—0.030
+ 0.007
+ 0.016
—0.040
—0.002
Tab. 3
Reproducibility in a series of analyses of blood plasma
Sample n o . 1 2 3 4
Test I free fatty acids
μ equiv./m/
Test II free fatty acids
μ equiv./m/
Test III free fatty acids
μ equiv./m/
0.690
0.698
—
0.120
0.120
0.118
0.828
0.817
0.822
1.374
1.365
—
0.659
0.665
0.667
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"Fig. 6
The arteriovenous difference of free fatty acids after injection of
250 μ£ of adrenaline
ο — ο arterial, · — · venous values
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Fig. 7
Free fatty acids in arterial and coronary venous blood of patients(n = 15) with heart failure in rest and during exercise
ο ο arterial, ·—· coronary venous values, Columns = arterio-
coronary-venous difference
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Determination of free fatty acids in plasma under diverse
conditions
1. Following an intravenous injection of 250 £ adrena-
line over a period of 2 min., a steep increase in the free
fatty acid content of both arterial and venous blood
was observed within 10 min. The arteriovenous differ-
ence, which before the injection of adrenaline is very
small, increased to a maximum after 10 min., and return-
ed to the original value after 20 min. The arterial blood
was sampled from the A. bracbialis dextra, and the
venous sample was obtained by inserting an approxi-
mately 20 cm long catheter deeply into the muscle
tissue of the left forearm (Fig. 6).
2. Arterio-coronary-venous difference in patients suffer-
ing from cardiac insufficiency were subjected to extreme
strain on a bicycle ergometer. As already reported for
athletes who go in for top-strain sports (8, 9), the con-
centration of free fatty acids in their blood is seen to
increase during the physical exertions. The concentration
of free fatty acids is at its greatest after 3 min. of maxi-
mum exertion. Obviously, the arterio-coronary-venous
difference during maximum exertion becomes greater
as a result of an increasing extraction of free fatty acids
by the heart muscle (Fig. 7).
3. The determination of free fatty acids in the plasma
of horses in rest and after a training of 20 min. was
made and the results are given in table 4.
Tab. 4
Free fatty acids ( equiv./rri/) in the plasma of horses in rest and
after training of 20 min.
horses rest after exercise
P.
P.
P. W.
R.
0.048
0.117
0.078
0.048
0.178
0.176
0.261
0.245
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Isolierung eines Xylose-haltigen Glykoproteids
aus dem Erythrocyten-Stroma1)
Von H. WEICKER
der Abtei lung für S to ff Wechselforschung (Leiter'. Prof. Dr. H. Weicker} der Medizinischen Universitäts-Poliklinik
Heidelberg (Direktor-. Prof. Dr. H. Plügge}
(Eingegangen am 27. März 1968)
Aus dem Erythrocyten-Stroma von 25 Blutspenderkonserven, die nach den Blütgruppeneigenschäften A, B, 0, MN, Rh und nach der
Länge der Lagerungszeit der Konserven klassifiziert worden waren, wurden mit dem Phenol-Wasser^System nach der Methode von
WESTPHAL und Mitarbeitern, modifiziert von UHLENBRUCK und Mitarbeitern, zwei chemisch und serologisch unterschiedliche Glyko^
proteide dargestellt.
Das Glykoproteid (W), isoliert aus der Wasser-Phase, enthält MN-Antigen und Virus-Rezeptoren. Wir konnten im wesentlichen die in
der Literatur beschriebenen chemischen Eigenschaften dieser Substanz bestätigen, fanden jedoch, daß die Ausbeute von den Blutgruppen-
eigenschaften und der Lagerungszeit der Konserven abhängig war. Bei 0- und AB-Erythrocyten war die Ausbeute am höchsten und zeigte
auch die geringste Beeinflussung durch längere Lagerungszeit. Entgegen den Befunden anderer Autoren fanden wir bei den M-Erythro-
cyten den höchsten Neuraminsäuregehalt, der bei 22—24% lag und zu 85—90% enzymatisch abspaltbar war. Die Kohlenhydrat-Kompo-
nenten des Glykoproteids (W) waren Galaktose, Mannose, Fucose in einer Verteilung von 4:2:1 sowie Galaktosamin, Glucosamin in
einer Verteilung von 5:3. Der Gesamtkohlenhydratgehalt betrug 37—41%. Insgesamt waren 16 Aminosäuren chromatographisch zu
identifizieren.
Das bis jetzt noch nicht beschriebene Glykoproteid (P) wurde aus der Phenol-Phase nach Entfernung der Lipide isoliert und enthielt
Xylose in einer Konzentration von 3—3,5%. Es hatte einen geringeren Neuraminsäuregehalt (8—10%) als das Glykoproteid (W). Die
Neuraminsäure war nur zu 60—70% abspaltbar. Seine Kohlenhydrat-Komponenten waren Galaktose, Mannose, Fucose, Xylose, Glucose
in einer Verteilung von 4:2:1:3:1 und Galaktosamin, Glucosamin in einer Verteilung von 3:2 bei einem Gesamtkohlenhydratgehalt von
20—25%. Die Aminosäure-Zusammensetzung zeigte keine wesentlichen Unterschiede zu dem Glykoproteid (W). Das Glykoproteid (P)
besaß keine MN-Antigen-Eigenschaften und hemmte die Virus-Hämagglutination nur geringfügig.
*) Mit Unterstützung der Deutschen Forschungsgemeinschaft. .
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